ONPH
ONCOLOGY PHARMA INC
Latest price
As of — · Market data by Massive
Market cap
—
Volume
0
Previous close
$0.0450
Day range
$0.0000 – $0.0000
Listed
—
Coverage
3 articles
Price performance
Recent trading
Newsroom
Latest ONPH coverage
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
[ad_1] San Francisco, CA – (NewMediaWire) – February 26, 2021 – Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has executed a world-wide Licensing Agreement with Sybleu Inc. for its Cancer therapy by intratumoral injection of a chemotherapeutic agent in combination with a bioactive immunostimulatory agent. The chemotherape
Oncology Pharma Announces the Appointment Of New Chief Financial Officer
[ad_1] San Francisco, CA – (NewMediaWire) – January 28, 2021 – Oncology Pharma Inc. (OTC: ONPH) is pleased to announce that it has retained the services of Mr. James Smith, CPA as its new Chief Financial Officer. Mr. James Smith, CPA is a seasoned executive officer with experience encompassing multiple public and priva
Oncology Pharma Announces Extension of Letter of Intent with Kalos Therapeutics, Retained an Interim CEO and Approval of Reverse Stock Split
[ad_1] San Francisco, CA – (NewMediaWire) – August 27, 2020 – Oncology Pharma, Inc. (OTCPK: ONPH) is pleased to announce that it has extended its Letter of Intent with Kalos Therapeutics. George Malasek was brought into the Company, as Interim CEO, to assist in moving the Company through its financing efforts. George is a finance ...